{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:24:39Z","timestamp":1771035879239,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jasc.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T02:53:49Z","timestamp":1547520829000},"page":"149-156","source":"Crossref","is-referenced-by-count":19,"title":["HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests"],"prefix":"10.1016","volume":"8","author":[{"given":"Yimin","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanne R.","family":"Mody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall J.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Armylagos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natu","family":"Puntachart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Hendrickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary R.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina R.","family":"Mody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2019.01.001_bib1","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMp058171","article-title":"The promise of global cervical-cancer prevention","volume":"353","author":"Schiffman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jasc.2019.01.001_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jasc.2019.01.001_bib3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2012.01.036","article-title":"Primary high-risk HPV screening for cervical cancer in post-menopausal women","volume":"125","author":"Gyllensten","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jasc.2019.01.001_bib4","doi-asserted-by":"crossref","first-page":"e7789","DOI":"10.1136\/bmj.e7789","article-title":"Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland","volume":"345","author":"Leinonen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jasc.2019.01.001_bib5","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/ijc.27850","article-title":"The HPV test has similar sensitivity but more overdiagnosis than the Pap test\u2014a randomised health services study on cervical cancer screening in Finland","volume":"132","author":"Malila","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2019.01.001_bib6","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/bjc.2012.489","article-title":"Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial\u2014the HPV FOCAL study","volume":"107","author":"Ogilvie","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jasc.2019.01.001_bib7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/bjc.2011.581","article-title":"HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications","volume":"106","author":"Rijkaart","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jasc.2019.01.001_bib8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jasc.2019.01.001_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/AOG.0000000000000669","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jasc.2019.01.001_bib11","doi-asserted-by":"crossref","first-page":"46.e1","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jasc.2019.01.001_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/1742-6413.132997","article-title":"Is 58% sensitivity for detection of cervical intraepithelial neoplasia 3 and invasive cervical cancer optimal for cervical screening?","volume":"11","author":"Austin","year":"2014","journal-title":"CytoJournal"},{"key":"10.1016\/j.jasc.2019.01.001_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncy.21687","article-title":"Clinical performance of the Food and Drug Administration-approved high-risk HPV test for the detection of high-grade cervicovaginal lesions","volume":"124","author":"Zhou","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib14","first-page":"w14559","article-title":"HPV-negative CIN3 and cervical cancer in Switzerland: any evidence of impact on screening policies?","volume":"147","author":"Vassilakos","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jasc.2019.01.001_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5858\/arpa.2014-0028-OA","article-title":"Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study","volume":"139","author":"Zhao","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2019.01.001_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/ajcp\/aqx027","article-title":"Polymerase chain reaction human papillomavirus (HPV) detection and HPV genotyping in invasive cervical cancers with prior negative HC2 test results","volume":"147","author":"Tao","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib18","series-title":"Diagnostic Pathology: Cytopathology","author":"Mody","year":"2014"},{"key":"10.1016\/j.jasc.2019.01.001_bib19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cncy.21210","article-title":"Should LSIL-H be a distinct cytology category? A study on the frequency and distribution of 40 human papillomavirus genotypes in 808 women","volume":"120","author":"Zhou","year":"2012","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib20","volume":"100B","year":"2009"},{"key":"10.1016\/j.jasc.2019.01.001_bib21","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study","volume":"50","author":"Szarewski","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jasc.2019.01.001_bib22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/JCM.03558-14","article-title":"Comparison of human papillomavirus detection by Aptima HPV and Cobas HPV tests in a population of women referred for colposcopy following detection of atypical squamous cells of undetermined significance by Pap cytology","volume":"53","author":"Castle","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jasc.2019.01.001_bib23","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1128\/JCM.01013-15","article-title":"Head-to-head comparison of the RNA-based Aptima human papillomavirus (HPV) assay and the DNA-based hybrid Capture 2 HPV test in a routine screening population of women aged 30 to 60 years in Germany","volume":"53","author":"Iftner","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jasc.2019.01.001_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/cncy.21875","article-title":"Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer","volume":"125","author":"Ge","year":"2017","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/dc.23003","article-title":"Immunocytochemical expression of P53, PTEN, FAS (CD95), P16INK4A and HPV L1 major capsid proteins in ThinPrep cervical samples with squamous intraepithelial lesions","volume":"42","author":"Grapsa","year":"2014","journal-title":"Diagn Cytopathol"},{"issue":"suppl 3","key":"10.1016\/j.jasc.2019.01.001_bib26","first-page":"C1","article-title":"HPV and cervical cancer in the world: 2007 report","volume":"25","author":"Castellsagu\u00e9","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jasc.2019.01.001_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jasc.2019.01.001_bib28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jasc.2019.01.001_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jasc.2013.06.001","article-title":"Genotype-specific prevalence and distribution of human papillomavirus genotypes in underserved Latino women with abnormal Papanicolaou tests","volume":"3","author":"Zhou","year":"2014","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib30","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.5858\/arpa.2012-0640-OA","article-title":"Unexpected high prevalence of HPV 90 infection in an underserved population: is it really a low-risk genotype?","volume":"137","author":"Quiroga-Garza","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2019.01.001_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012816","article-title":"Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity","volume":"5","author":"Fu","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2019.01.001_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jcp.57.1.68","article-title":"Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population","volume":"57","author":"Cuschieri","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/1055-9965.EPI-09-0983","article-title":"Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys","volume":"19","author":"Vaccarella","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jasc.2019.01.001_bib34","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/dc.23143","article-title":"Genotypes and prevalence of HPV single and multiple concurrent infections in women with HSIL","volume":"42","author":"Beca","year":"2014","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2019.01.001_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000442512","article-title":"Multiple human papilloma virus infections and their impact on the development of high-risk cervical lesions","volume":"59","author":"Salazar","year":"2015","journal-title":"Acta Cytol"},{"key":"10.1016\/j.jasc.2019.01.001_bib36","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1158\/1055-9965.EPI-05-0465","article-title":"Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections","volume":"14","author":"Chaturvedi","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jasc.2019.01.001_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/LGT.0b013e3182a577c7","article-title":"Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction","volume":"18","author":"Hopenhayn","year":"2014","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2019.01.001_bib38","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221329451830406X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221329451830406X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T21:13:49Z","timestamp":1557782029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221329451830406X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S221329451830406X"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2019.01.001","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]}}}